Screening Embryos for Polygenic Conditions and Traits: Ethical Considerations for an Emerging Technology

Gabriel Lázaro-Muñoz; Stacey Pereira; Shai Carmi; Todd Lencz

doi:10.1212/01.CON.0000771668.22235.98

Screening Embryos for Polygenic Conditions and Traits: Ethical Considerations for an Emerging Technology

Gabriel Lázaro-Muñoz, Stacey Pereira, Shai Carmi, Todd Lencz

Department of Social Medicine

Research output: Contribution to journal › Comment/debate

Abstract

(Abstracted from Genet Med 2021;23:432-434) Polygenic embryo screening (PES) uses polygenic risk scores (PRSs) to estimate risk for complex disorders and traits as a part of preimplantation genetic testing (PGT). Preimplantation genetic testing has been used for many years in order to avoid transferring embryos that have aneuploidies or single gene Mendelian disorders.

Original language	American English
Pages (from-to)	458-459
Number of pages	2
Journal	Obstetrical and Gynecological Survey
Volume	76
Issue number	8
DOIs	https://doi.org/10.1212/01.CON.0000771668.22235.98
State	Published - 2021

Bibliographical note

Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.

Access to Document

10.1212/01.CON.0000771668.22235.98

Cite this

@article{85da7901ca944a56bdc7729e98e8f68f,

title = "Screening Embryos for Polygenic Conditions and Traits: Ethical Considerations for an Emerging Technology",

abstract = "(Abstracted from Genet Med 2021;23:432-434) Polygenic embryo screening (PES) uses polygenic risk scores (PRSs) to estimate risk for complex disorders and traits as a part of preimplantation genetic testing (PGT). Preimplantation genetic testing has been used for many years in order to avoid transferring embryos that have aneuploidies or single gene Mendelian disorders.",

author = "Gabriel L{\'a}zaro-Mu{\~n}oz and Stacey Pereira and Shai Carmi and Todd Lencz",

year = "2021",

doi = "10.1212/01.CON.0000771668.22235.98",

language = "American English",

volume = "76",

pages = "458--459",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "8",

}

TY - JOUR

T1 - Screening Embryos for Polygenic Conditions and Traits

T2 - Ethical Considerations for an Emerging Technology

AU - Lázaro-Muñoz, Gabriel

AU - Pereira, Stacey

AU - Carmi, Shai

AU - Lencz, Todd

PY - 2021

Y1 - 2021

N2 - (Abstracted from Genet Med 2021;23:432-434) Polygenic embryo screening (PES) uses polygenic risk scores (PRSs) to estimate risk for complex disorders and traits as a part of preimplantation genetic testing (PGT). Preimplantation genetic testing has been used for many years in order to avoid transferring embryos that have aneuploidies or single gene Mendelian disorders.

AB - (Abstracted from Genet Med 2021;23:432-434) Polygenic embryo screening (PES) uses polygenic risk scores (PRSs) to estimate risk for complex disorders and traits as a part of preimplantation genetic testing (PGT). Preimplantation genetic testing has been used for many years in order to avoid transferring embryos that have aneuploidies or single gene Mendelian disorders.

UR - http://www.scopus.com/inward/record.url?scp=85113423282&partnerID=8YFLogxK

U2 - 10.1212/01.CON.0000771668.22235.98

DO - 10.1212/01.CON.0000771668.22235.98

M3 - Comment/debate

AN - SCOPUS:85113423282

SN - 0029-7828

VL - 76

SP - 458

EP - 459

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

IS - 8

ER -

Screening Embryos for Polygenic Conditions and Traits: Ethical Considerations for an Emerging Technology

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this